Upon filtering DEGs, using the TCGA PRAD cohort and performing overall survival analysis, we revealed overexpression of ANLN and ECT2 to be significantly associated with poor survival of PCa patients in TCGA PRAD cohort (p = 0.0402; p = 0.0414, respectively) (Figure 3A,B). The gene discussed is ANLN; the disease is prostate adenocarcinoma.